comparemela.com

Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress

Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Milan ,Lombardia ,Italy ,Irina Koffler ,Paul Spencer ,Tiziana Life Sciences Ltd ,Research In Multiple Sclerosis ,Research Of Multiple Sclerosis ,Nasdaq ,Business Development ,Tiziana Life Sciences ,Lifesci Advisors ,European Committee For Treatment ,Announces Presentation ,Six Month Safety ,Biomarker Data ,Intranasal Foralumab ,Six Non Active Secondary Progressive ,Life Sciences ,European Committee ,Multiple Sclerosis ,Tiziana Life ,Investor Relations ,Sci Advisors ,

comparemela.com © 2020. All Rights Reserved.